← Back to headlines
Profusa Granted Transfer to Nasdaq Capital Market, Faces Compliance Deadline
Profusa, a medical technology company, has been granted a transfer to the Nasdaq Capital Market but must meet a compliance deadline in July.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
